Cargando…
The expression and function of RASAL2 in renal cell carcinoma angiogenesis
Patients with renal cell carcinoma (RCC) often develop resistance to antivascular drugs and eventually succumb to disease. However, the underlying molecular mechanism remains poorly understood. In this study, we demonstrated that RASAL2, a RAS GTPase-activating protein, played a tumor-suppressive ro...
Autores principales: | Hui, Ke, Yue, Yangyang, Wu, Shiqi, Gu, Yanan, Guan, Bing, Wang, Xinyang, Hsieh, Jer-Tsong, Chang, Luke S., He, Dalin, Wu, Kaijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115459/ https://www.ncbi.nlm.nih.gov/pubmed/30158581 http://dx.doi.org/10.1038/s41419-018-0898-x |
Ejemplares similares
-
RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
por: Hui, Ke, et al.
Publicado: (2017) -
RASAL2 regulates the cell cycle and cyclin D1 expression through PI3K/AKT signalling in prostate tumorigenesis
por: Wang, Qi, et al.
Publicado: (2022) -
MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma
por: Yue, Yangyang, et al.
Publicado: (2020) -
The AKR1C3/AR‐V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression
por: Wang, Bin, et al.
Publicado: (2020) -
Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus
por: Zhang, Tingting, et al.
Publicado: (2015)